The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rhode Island state lawmakers last week introduced bills that would prohibit both differentiated payments from pharmacy benefit managers (PBMs) to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A senior Indiana state senator introduced a bill this week that would require 340B providers to annually report detailed financial [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
